688235.SH
BeOne Medicines Ltd.
SSE · Healthcare · Biotechnology · CN
CNY 276.67
−4.35%Year over year
Reported trailing growth
- Revenue
- +36.2%
- EBITDA
- —
- EBIT
- +295.4%
- EPS
- —
- Free cash flow
- +953.7%
- Operating cash flow
- +1516.8%
Forward estimates
Based on analyst estimates
- Revenue
- -82.4%
- EBITDA
- -61.3%
- EPS
- -41.9%
Three-year CAGR
- Revenue
- +58.7%
- EBITDA
- +223.0%
- EBIT
- +162.5%
- Net income
- +129.3%
- EPS
- +128.3%
- Free cash flow
- +362.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026